APO Research, Inc.

APO RESEARCH · REPORT

Iobitrol Injection

Selected research

Market Outlook & Growth Opportunities

Global Iobitrol Injection Market Outlook and Growth Opportunities 2026

Market perspective

The global Iobitrol Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Iobitrol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Iobitrol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Iobitrol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Iobitrol Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Iobitrol Injection market include Guerbet, Brilliant Pharmaceutical and Shenghuaxi Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Iobitrol Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Iobitrol Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Iobitrol Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Iobitrol Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Iobitrol Injection Segment by Company

Guerbet

Brilliant Pharmaceutical

Shenghuaxi Pharmaceutical

Iobitrol Injection Segment by Type

75ml

50ml

100ml

Iobitrol Injection Segment by Application

Hospital

Clinic

Others

Iobitrol Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Iobitrol Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Iobitrol Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Iobitrol Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Iobitrol Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iobitrol Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Iobitrol Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iobitrol Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Iobitrol Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Iobitrol Injection industry.

Chapter 3: Detailed analysis of Iobitrol Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Iobitrol Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Iobitrol Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Iobitrol Injection Industry Trends Table 2. Iobitrol Injection Industry Drivers Table 3. Iobitrol Injection Industry Opportunities and Challenges Table 4. Iobitrol Injection Industry Restraints Table 5. Global Iobitrol Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Iobitrol Injection Revenue Share by Company (2021-2026) Table 7. Global Iobitrol Injection Sales Volume by Company (Units) & (2021-2026) Table 8. Global Iobitrol Injection Sales Volume Share by Company (2021-2026) Table 9. Global Iobitrol Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Iobitrol Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Iobitrol Injection Key Company Manufacturing Base & Headquarters Table 12. Global Iobitrol Injection Company, Product Type & Application Table 13. Global Iobitrol Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Iobitrol Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 75ml Table 18. Significant Companies of 50ml Table 19. Significant Companies of 100ml Table 20. Global Iobitrol Injection Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global Iobitrol Injection Sales Volume by Type (2021-2026) & (Units) Table 22. Global Iobitrol Injection Sales Volume by Type (2027-2032) & (Units) Table 23. Global Iobitrol Injection Sales Volume Share by Type (2021-2026) Table 24. Global Iobitrol Injection Sales Volume Share by Type (2027-2032) Table 25. Global Iobitrol Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Iobitrol Injection Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Iobitrol Injection Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Iobitrol Injection Sales Value Share by Type (2021-2026) Table 29. Global Iobitrol Injection Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Others Table 33. Global Iobitrol Injection Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 34. Global Iobitrol Injection Sales Volume by Application (2021-2026) & (Units) Table 35. Global Iobitrol Injection Sales Volume by Application (2027-2032) & (Units) Table 36. Global Iobitrol Injection Sales Volume Share by Application (2021-2026) Table 37. Global Iobitrol Injection Sales Volume Share by Application (2027-2032) Table 38. Global Iobitrol Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Iobitrol Injection Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Iobitrol Injection Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Iobitrol Injection Sales Value Share by Application (2021-2026) Table 42. Global Iobitrol Injection Sales Value Share by Application (2027-2032) Table 43. Global Iobitrol Injection Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 44. Global Iobitrol Injection Sales by Region (2021-2026) & (Units) Table 45. Global Iobitrol Injection Sales Market Share by Region (2021-2026) Table 46. Global Iobitrol Injection Sales by Region (2027-2032) & (Units) Table 47. Global Iobitrol Injection Sales Market Share by Region (2027-2032) Table 48. Global Iobitrol Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Iobitrol Injection Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Iobitrol Injection Sales Value Share by Region (2021-2026) Table 51. Global Iobitrol Injection Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Iobitrol Injection Sales Value Share by Region (2027-2032) Table 53. Global Iobitrol Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Iobitrol Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Iobitrol Injection Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 56. Global Iobitrol Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Iobitrol Injection Sales by Country (2021-2026) & (Units) Table 58. Global Iobitrol Injection Sales Market Share by Country (2021-2026) Table 59. Global Iobitrol Injection Sales by Country (2027-2032) & (Units) Table 60. Global Iobitrol Injection Sales Market Share by Country (2027-2032) Table 61. Global Iobitrol Injection Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Iobitrol Injection Sales Value Market Share by Country (2021-2026) Table 63. Global Iobitrol Injection Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Iobitrol Injection Sales Value Market Share by Country (2027-2032) Table 65. Guerbet Company Information Table 66. Guerbet Business Overview Table 67. Guerbet Iobitrol Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Guerbet Iobitrol Injection Product Portfolio Table 69. Guerbet Recent Development Table 70. Brilliant Pharmaceutical Company Information Table 71. Brilliant Pharmaceutical Business Overview Table 72. Brilliant Pharmaceutical Iobitrol Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Brilliant Pharmaceutical Iobitrol Injection Product Portfolio Table 74. Brilliant Pharmaceutical Recent Development Table 75. Shenghuaxi Pharmaceutical Company Information Table 76. Shenghuaxi Pharmaceutical Business Overview Table 77. Shenghuaxi Pharmaceutical Iobitrol Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Shenghuaxi Pharmaceutical Iobitrol Injection Product Portfolio Table 79. Shenghuaxi Pharmaceutical Recent Development Table 80. Key Raw Materials Table 81. Raw Materials Key Suppliers Table 82. Iobitrol Injection Distributors List Table 83. Iobitrol Injection Customers List Table 84. Research Programs/Design for This Report Table 85. Authors List of This Report Table 86. Secondary Sources Table 87. Primary Sources List of Figures Figure 1. Iobitrol Injection Product Image Figure 2. Global Iobitrol Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Iobitrol Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Iobitrol Injection Sales (2021-2032) & (Units) Figure 5. Global Iobitrol Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Iobitrol Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 75ml Image Figure 10. 50ml Image Figure 11. 100ml Image Figure 12. Global Iobitrol Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global Iobitrol Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Iobitrol Injection Sales Volume Share by Type (2021-2032) Figure 15. Global Iobitrol Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Iobitrol Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Iobitrol Injection Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Others Image Figure 21. Global Iobitrol Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 22. Global Iobitrol Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Iobitrol Injection Sales Volume Share by Application (2021-2032) Figure 24. Global Iobitrol Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Iobitrol Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Iobitrol Injection Sales Value Share by Application (2021-2032) Figure 27. Global Iobitrol Injection Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 28. Global Iobitrol Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Iobitrol Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Iobitrol Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Iobitrol Injection Sales Value (2021-2032) & (US$ Million) Figure 32. North America Iobitrol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Iobitrol Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Iobitrol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Iobitrol Injection Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Iobitrol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Iobitrol Injection Sales Value (2021-2032) & (US$ Million) Figure 38. South America Iobitrol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Iobitrol Injection Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Iobitrol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Iobitrol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Iobitrol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Iobitrol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Iobitrol Injection Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Iobitrol Injection Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 75ml
  • 50ml
  • 100ml
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Guerbet
  • Brilliant Pharmaceutical
  • Shenghuaxi Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Iobitrol Injection Sales Value (2021-2032)
  4. 1.2.2 Global Iobitrol Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Iobitrol Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Iobitrol Injection Market Dynamics
  1. 2.1 Iobitrol Injection Industry Trends
  2. 2.2 Iobitrol Injection Industry Drivers
  3. 2.3 Iobitrol Injection Industry Opportunities and Challenges
  4. 2.4 Iobitrol Injection Industry Restraints
3 Iobitrol Injection Market by Company
  1. 3.1 Global Iobitrol Injection Company Revenue Ranking in 2025
  2. 3.2 Global Iobitrol Injection Revenue by Company (2021-2026)
  3. 3.3 Global Iobitrol Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Iobitrol Injection Average Price by Company (2021-2026)
  5. 3.5 Global Iobitrol Injection Company Ranking (2024-2026)
  6. 3.6 Global Iobitrol Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Iobitrol Injection Company Product Type and Application
  8. 3.8 Global Iobitrol Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Iobitrol Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Iobitrol Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Iobitrol Injection Market by Type
  1. 4.1 Iobitrol Injection Type Introduction
  2. 4.1.1 75ml
  3. 4.1.2 50ml
  4. 4.1.3 100ml
  5. 4.2 Global Iobitrol Injection Sales Volume by Type
  6. 4.2.1 Global Iobitrol Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Iobitrol Injection Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Iobitrol Injection Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Iobitrol Injection Sales Value by Type
  10. 4.3.1 Global Iobitrol Injection Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Iobitrol Injection Sales Value by Type (2021-2032)
  12. 4.3.3 Global Iobitrol Injection Sales Value Share by Type (2021-2032)
5 Iobitrol Injection Market by Application
  1. 5.1 Iobitrol Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Iobitrol Injection Sales Volume by Application
  6. 5.2.1 Global Iobitrol Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Iobitrol Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Iobitrol Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Iobitrol Injection Sales Value by Application
  10. 5.3.1 Global Iobitrol Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Iobitrol Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Iobitrol Injection Sales Value Share by Application (2021-2032)
6 Iobitrol Injection Regional Sales and Value Analysis
  1. 6.1 Global Iobitrol Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Iobitrol Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Iobitrol Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Iobitrol Injection Sales by Region (2027-2032)
  5. 6.3 Global Iobitrol Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Iobitrol Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Iobitrol Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Iobitrol Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Iobitrol Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Iobitrol Injection Sales Value (2021-2032)
  12. 6.6.2 North America Iobitrol Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Iobitrol Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Iobitrol Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Iobitrol Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Iobitrol Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Iobitrol Injection Sales Value (2021-2032)
  21. 6.9.2 South America Iobitrol Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Iobitrol Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Iobitrol Injection Sales Value Share by Country, 2025 VS 2032
7 Iobitrol Injection Country-level Sales and Value Analysis
  1. 7.1 Global Iobitrol Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Iobitrol Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Iobitrol Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Iobitrol Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Iobitrol Injection Sales by Country (2027-2032)
  6. 7.4 Global Iobitrol Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Iobitrol Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Iobitrol Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Iobitrol Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Iobitrol Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Iobitrol Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Iobitrol Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Iobitrol Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Iobitrol Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Iobitrol Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Iobitrol Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Iobitrol Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Iobitrol Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Iobitrol Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Iobitrol Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Iobitrol Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Iobitrol Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Iobitrol Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Iobitrol Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Iobitrol Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Iobitrol Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Iobitrol Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Iobitrol Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Iobitrol Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Iobitrol Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Iobitrol Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Iobitrol Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Iobitrol Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Iobitrol Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Iobitrol Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Iobitrol Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Guerbet
  2. 8.1.1 Guerbet Company Information
  3. 8.1.2 Guerbet Business Overview
  4. 8.1.3 Guerbet Iobitrol Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Guerbet Iobitrol Injection Product Portfolio
  6. 8.1.5 Guerbet Recent Developments
  7. 8.2 Brilliant Pharmaceutical
  8. 8.2.1 Brilliant Pharmaceutical Company Information
  9. 8.2.2 Brilliant Pharmaceutical Business Overview
  10. 8.2.3 Brilliant Pharmaceutical Iobitrol Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Brilliant Pharmaceutical Iobitrol Injection Product Portfolio
  12. 8.2.5 Brilliant Pharmaceutical Recent Developments
  13. 8.3 Shenghuaxi Pharmaceutical
  14. 8.3.1 Shenghuaxi Pharmaceutical Company Information
  15. 8.3.2 Shenghuaxi Pharmaceutical Business Overview
  16. 8.3.3 Shenghuaxi Pharmaceutical Iobitrol Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shenghuaxi Pharmaceutical Iobitrol Injection Product Portfolio
  18. 8.3.5 Shenghuaxi Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Iobitrol Injection Value Chain Analysis
  2. 9.1.1 Iobitrol Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Iobitrol Injection Sales Mode & Process
  6. 9.2 Iobitrol Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Iobitrol Injection Distributors
  9. 9.2.3 Iobitrol Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.